Dr Pietro Canetta reflects on how the rapidly advancing field of IgA nephropathy research has transformed from limited ...
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...
A brand of dried lily flowers have been recalled by the U.S. Food and Drug Administration after undeclared sulfites were ...
Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study ...
Washington company Wild Coast Raw issued a voluntary recall for its Frozen Boneless Free Range Chicken Formula on March 1, ...
Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.
The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.
Looking ahead to 2025, Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies.